The effect of bilirubin on long-term mortality in patients with chronic total coronary occlusion

Göster/Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2019Yazar
Çetin, MustafaDurakoğlugil, Murtaza Emre
Erdoğan, Turan
Özer, Savaş
Turan, Oğuzhan Ekrem
Yılmaz, Ahmet Seyda
Akdoğan, Emin
Üst veri
Tüm öğe kaydını gösterKünye
Cetin, M., Durakoglugil, M. E., Erdogan, T., Ozer, S., Turan, O. E., Yilmaz, A. S., & Akdogan, E. (2019). The effect of bilirubin on long-term mortality in patients with chronic total coronary occlusion. Bratislavske lekarske listy, 120(11), 860–863. https://doi.org/10.4149/BLL_2019_143Özet
AIM: We intended to investigate the association of bilirubin with total mortality in patients with chronic total coronary occlusion (CTO). METHODS: We included 172 patients who underwent coronary angiography due to stable angina pectoris and had CTO. We checked the viability of patients after 9 years of follow-up. RESULTS: Direct bilirubin levels were significantly lower in the non-viable group. We revealed age (OR = 1.045, 95% C.I: 1.009.1.083; p = 0.015) and direct bilirubin concentrations (OR = 0.029, 95% C.I: 0.002.0.435; p = 0.029) as independent predictors of mortality. Direct bilirubin value of > 0.2 mg/dL was associated with decreased mortality with a sensitivity of 85 %, and a specificity of 46 %. CONCLUSION: Serum direct bilirubin concentrations independently predict total mortality in patients with chronic total occlusion over 9 years of follow-up (Tab. 1, Fig. 2, Ref. 23).